Sun Pharma Gets Regulatory Nod In Australia For Acne Treatment Cream

Sun Pharma Gets Regulatory Nod In Australia For Acne Treatment Cream

The approval is for Winlevi, which is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

PTIUpdated: Tuesday, March 19, 2024, 10:21 AM IST
article-image
Sun Pharma | Image: Wikipedia (Representative)

Sun Pharmaceutical Industries Ltd on Tuesday said the Australian Therapeutic Goods Administration has granted regulatory approval for Winlevi cream indicated for the topical treatment of acne.

The approval is for Winlevi (clascoterone cream 1 per cent), which is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older, the company said in a statement.

Sun Pharma received the exclusive right to develop and commercialise Winlevi in the US, Japan, Australia, New Zealand, Brazil, Mexico, and Russia from Cosmo, it added.

"Winlevi is an exciting addition to our expanding dermatology portfolio of innovative medicines in Australia. Winlevi's novel mechanism of action will be a welcome addition to the physician's toolkit while treating acne," Hellen de Kloet, Business Head, Western Europe, Australia and New Zealand, Sun Pharma, said.

The company said Winlevi will be available in Australia this June.

"This is another achievement in the mission of Cosmo and Sun Pharma to improve the lives of patients affected by skin conditions," Cosmo President of the Dermatology Division Diana Harbort said. 

RECENT STORIES

Lodha Developers To Launch ₹17,000 Crore Housing Projects By March 2026, Confident Of ₹21,000...

Lodha Developers To Launch ₹17,000 Crore Housing Projects By March 2026, Confident Of ₹21,000...

Canara Bank To Sell Surplus Priority Sector Loans In Q2 To Offset NIM Pressure From Rate Cuts

Canara Bank To Sell Surplus Priority Sector Loans In Q2 To Offset NIM Pressure From Rate Cuts

Indian Railways Deactivates 2.5 Crore IRCTC User IDs, Confirmed Tickets Now Easier; Booking System...

Indian Railways Deactivates 2.5 Crore IRCTC User IDs, Confirmed Tickets Now Easier; Booking System...

Lodha Developers To Launch ₹17,000 Crore Housing Projects By March Amid High Demand Surge

Lodha Developers To Launch ₹17,000 Crore Housing Projects By March Amid High Demand Surge

ED Raids On Anil Ambani Firms Conclude, Reliance Power & Infra Say Operations Unaffected

ED Raids On Anil Ambani Firms Conclude, Reliance Power & Infra Say Operations Unaffected